Novo Nordisk disclosed a data breach that exposed pseudonymized clinical trial patient information and personal details belonging to an undisclosed number of healthcare professionals. The company said the attackers copied non-public data from internal IT systems, but that the exposed trial data does not directly identify patients by name. #NovoNordisk
Keypoints
- Novo Nordisk confirmed unauthorized access to its internal IT systems.
- The breach exposed clinical trial data linked to patients, including biomarkers and lifestyle factors.
- The company said the patient data was pseudonymized and not directly tied to names.
- Healthcare professionals had names, contact details, and office locations exposed.
- Novo Nordisk warned HCPs about possible phishing attempts using the stolen information.